SYNOVIAL FLUID ANALYSIS

SYNOVIAL FLUID ANALYSIS was reported 87 times

SYNOVIAL FLUID ANALYSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 alpha-1 Adrenergic Agonist [EPC] 8 0.0018
1 Purine Antimetabolite [EPC] 79 0.0008
2 Aminosalicylate [EPC] 79 0.0008
3 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 56 0.0006
4 Antirheumatic Agent [EPC] 37 0.0003
5 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 3 0.0003
6 Interleukin-6 Receptor Antagonist [EPC] 39 0.0003
7 Selective T Cell Costimulation Modulator [EPC] 39 0.0003
8 Vitamin D [EPC] 79 0.0003
9 Vitamin B12 [EPC] 79 0.0002
10 beta Lactamase Inhibitor [EPC] 1 0.0002
11 Human Immunoglobulin G [EPC] 4 0.0002
12 Vitamin C [EPC] 79 0.0002
13 Xanthine Oxidase Inhibitor [EPC] 32 0.0002
14 Folate Analog Metabolic Inhibitor [EPC] 75 0.0002
15 Histamine-1 Receptor Antagonist [EPC] 13 0.0002
16 CD20-directed Cytolytic Antibody [EPC] 38 0.0001
17 Tetracycline-class Drug [EPC] 6 0.0001
18 Tumor Necrosis Factor Blocker [EPC] 80 0.0001
19 Proton Pump Inhibitor [EPC] 46 0.0001
20 Opioid Agonist [EPC] 18 0.0001
21 Corticosteroid [EPC] 78 0.0001
22 Nonsteroidal Anti-inflammatory Drug [EPC] 77 0.0001
23 Antimetabolite Immunosuppressant [EPC] 1 0.0000
24 Methylxanthine [EPC] 2 0.0000
25 Provitamin D2 Compound [EPC] 1 0.0000
26 Central Nervous System Stimulant [EPC] 2 0.0000
27 beta3-Adrenergic Agonist [EPC] 1 0.0000
28 Expectorant [EPC] 4 0.0000
29 Interleukin-12 Antagonist [EPC] 2 0.0000
30 Interleukin-23 Antagonist [EPC] 2 0.0000
31 Macrolide Antimicrobial [EPC] 1 0.0000
32 Phosphodiesterase 4 Inhibitor [EPC] 3 0.0000
33 Fluoroquinolone Antibacterial [EPC] 2 0.0000
34 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
35 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
36 Calcium [EPC] 1 0.0000
37 Benzodiazepine [EPC] 3 0.0000
38 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
39 Platelet Aggregation Inhibitor [EPC] 1 0.0000